Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer

By Rajan Suja  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 511-520

Springer Publishing Company

Access to resources Recommend Favorite

A Randomised Study Comparing Granulocyte-colony Stimulating Factor (G-CSF) with G-CSF Plus Thymostimulin in the Treatment of Haematological Toxicity in Patients with Advanced Breast Cancer after High Dose Mitoxantrone Therapy

By Sanchiz F.   Milla A.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 52-56

Elsevier

Access to resources Recommend Favorite

Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study

By Frasci Giuseppe   Comella Pasquale   D'Aiuto Giuseppe   Budillon Alfredo   Barbarulo Deborah   Thomas Renato   Capasso Immacolata   Casaretti Rossana   Daponte Antonio   Caponigro Francesco   Gravina Adriano   Maiorino Luigi   Caratení Giacomo   Gentile Alfonso   Comella Giuseppe  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 13-26

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel and cyclophosphamide as adjuvant chemotherapy for early breast cancer: primary prophylaxis with G-CSF is required

By Lakhanpal Roopa   Stuart-Harris Robin   Chan Arlene   Kotasek Dusan   Beith Jane   Cuff Katharine   Bastick Patricia   Lee Clara  

Breast Cancer Management, Vol. 2, Iss. 5, 2013-09 ,pp. : 367-374

Future Medicine

Access to resources Recommend Favorite

Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

By Shikata Hisaharu   Yakushijin Yoshihiro   Yamanouchi Jun   Azuma Taichi   Yasukawa Masaki  

International Journal of Clinical Oncology, Vol. 19, Iss. 1, 2014-02 ,pp. : 178-185

Springer Publishing Company

Access to resources Recommend Favorite